Protonix and Ubrelvy drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Protonix (pantoprazole sodium) and Ubrelvy (ubrogepant). Common drug interactions include arthralgia among females and gallbladder disorder among males.

The phase IV clinical study analyzes what interactions people have when they take Protonix and Ubrelvy. It is created by eHealthMe based on reports of 34 people who take the same drugs from the FDA, and is updated regularly.

What is Protonix?

Protonix has active ingredients of pantoprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 132,658 Protonix users. Check the latest studies of Protonix.

What is Ubrelvy?

Ubrelvy has active ingredients of ubrogepant. eHealthMe is studying from 3,585 Ubrelvy users. Check the latest studies of Ubrelvy.

On Jul, 21, 2026

34 people who take Protonix and Ubrelvy together, and have interactions are studied.

What are the common drug interactions of Protonix and Ubrelvy, by gender? *:

female:

Arthralgia (joint pain)
Migraine (headache)
Rash
Chest pain
Diarrhoea haemorrhagic (bloody diarrhoea)
Fluid retention (an abnormal accumulation of fluid in the blood)
Headache (pain in head)
Hypotension (abnormally low blood pressure)
Ileus (a painful obstruction of the ileum or other part of the intestine)
Infusion related reaction

male:

Gallbladder disorder
Drug ineffective
Hypertension (high blood pressure)
Irritability
Migraine (headache)
Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)

What are the common drug interactions of Protonix and Ubrelvy, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Dental caries
Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
Tooth erosion (dissolving teeth)
Tooth loss

30-39:

Rash
Lymphadenopathy (disease or enlargement of lymph nodes)
Pain
Pruritus (severe itching of the skin)
White blood cell count decreased

40-49:

Abdominal pain upper
Bone pain
Chest discomfort
Diarrhoea
Dry mouth
Dyspepsia (indigestion)
Dyspnoea (difficult or laboured respiration)
Injection site pain
Migraine (headache)
Nausea (feeling of having an urge to vomit)

50-59:

Adverse drug reaction
Asthma
Cough
Dyspnoea (difficult or laboured respiration)
Hypertension (high blood pressure)

60+:

Drug ineffective
Aphasia (damage to the parts of the brain that control language)
Nausea (feeling of having an urge to vomit)
Urinary tract infection
Vomiting
Aura
Mental impairment (a condition affecting the body, perhaps through sight or hearing loss, a mobility difficulty or a health condition)
Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
Pneumonia
Back pain

What are the existing conditions these people have? *

Migraine (headache): 15 people, 44.12%
Immunodeficiency Common Variable: 7 people, 20.59%
Pain: 5 people, 14.71%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 4 people, 11.76%
Asthma: 4 people, 11.76%
Nausea (feeling of having an urge to vomit): 3 people, 8.82%
Stress And Anxiety: 2 people, 5.88%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 5.88%
Psoriasis (immune-mediated disease that affects the skin): 2 people, 5.88%
Multiple Myeloma (cancer of the plasma cells): 2 people, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Protonix and Ubrelvy?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously